OOIR: Observatory of International Research

Papers

(The median citation count of World Journal of Biological Psychiatry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Resting-state network dysconnectivity in ADHD: A system-neuroscience-based meta-analysis	77
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood	46
The biology of burnout: Causes and consequences	45
The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe	39
Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance	37
The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders	30
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?	27
Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review	27
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis	25
Frontal GABA in schizophrenia: A meta-analysis of ¹H-MRS studies	24
Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?	24
Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyl	22
Diminished levels of the chemokine fractalkine in post-mortem prefrontal cortex in schizophrenia but not bipolar disorder	20
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders	19
Lifetime and current depression in the German National Cohort (NAKO)	18
Altered dynamic parahippocampus functional connectivity in patients with post-traumatic stress disorder	17
High-lethality of suicide attempts associated with platelet to lymphocyte ratio and mean platelet volume in psychiatric inpatient setting	17
Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia	17
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders	16
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants	16
Circulating cell-free mitochondrial DNA in brain health and disease: A systematic review and meta-analysis	13
The hypothalamic-pituitary-adrenal axis in the perinatal period: Its relationship with major depressive disorder and early life adversity	13
Executive functioning and emotion recognition in youth with oppositional defiant disorder and/or conduct disorder	13
Growth factors in anorexia nervosa: a systematic review and meta-analysis of cross-sectional and longitudinal data	13
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD	13

Transcriptomic profiling as biological markers of depression – A pilot study in unipolar and bipolar women	13
Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol	13
Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependence	12
Sleep-related traits and attention-deficit/hyperactivity disorder comorbidity: Shared genetic risk factors, molecular mechanisms, and causal effects	12
Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition	12
Characterising phospholipids and free fatty acids in patients with schizophrenia: A case-control study	12
Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis	12
Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder	11
Sex differences in the association between symptoms and superoxide dismutase in patients with never-treated first-episode schizophrenia	11
The assessment of childhood maltreatment and its associations with affective symptoms in adulthood: Results of the German National Cohort (NAKO)	11
Correlation between S100B and severity of depression in MDD: A meta-analysis	11
SNX29, a new susceptibility gene shared with major mental disorders in Han Chinese population	10
Microglia and HPA axis in depression: An overview of participation and relationship	10
Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine	10
Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids	9
Spend time outdoors for your brain – an in-depth longitudinal MRI study	9
Effects of low-dose alcohol exposure in adolescence on subsequent alcohol drinking in adulthood in a rat model of depression	9
Differential methylation of imprinting genes and MHC locus in 22q11.2 deletion syndrome-related schizophrenia spectrum disorders	9
The similar eye movement dysfunction between major depressive disorder, bipolar depression and bipolar mania	9
Circulating inflammatory markers, cell-free mitochondrial DNA, cortisol, endocannabinoids, and N-acylethanolamines in female depressed outpatients	9
Oral ketamine for depression: An updated systematic review	9
The value of ‘mega cohorts’ for psychiatric research	8
Malignant catatonia: Severity, treatment and outcome – a systematic case series analysis	8
The assessment of cognitive function in the German National Cohort (NAKO) – Associations of demographics and psychiatric symptoms with cognitive test performance	8
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience	8
Hippocampal functional network: The mediating role between obsession and anxiety in adult patients with obsessive-compulsive disorder	8
Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study	8
An overview of the human brain myelin proteome and differences associated with schizophrenia	8
Modulation of the prefrontal blood oxygenation response to intermittent theta-burst stimulation in depression: A sham-controlled study with functional near-infrared spectroscopy	8
Impaired response inhibition during a stop-signal task in children with Tourette syndrome is related to ADHD symptoms: A functional magnetic resonance imaging study	8
Newborn differential DNA methylation and subcortical brain volumes as early signs of severe neurodevelopmental delay in a South African Birth Cohort Study	8
Mitochondria’s role in sleep: Novel insights from sleep deprivation and restriction studies	8
Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study	7
Genetic variants in miRNAs differentially expressed during brain development and their relevance to psychiatric disorders susceptibility	7
Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer’s disease	7
Autonomic nervous system activity and dialectical behavioral therapy outcome in adolescent borderline personality pathology	7
Severe mental disorders and vaccinations – a systematic review	7
Seasonality of plasma tryptophan and kynurenine in pregnant mothers with a history of seasonal affective disorder: Vulnerability or adaptation?	7
Novel plasma metabolite markers of attention-deficit/hyperactivity disorder identified using high-performance chemical isotope labelling-based liquid chromatography-mass spectrometry	7
The potential of biomarkers for diagnosing insomnia: Consensus statement of the WFSBP Task Force on Sleep Disorders	7
Generalised anxiety and panic symptoms in the German National Cohort (NAKO)	7
Amygdala structure and function in paediatric bipolar disorder and high-risk youth: A systematic review of magnetic resonance imaging findings	7
Evolution of BDNF serum levels during the first six months after alcohol withdrawal	7
Targeted sequencing approach: Comprehensive analysis of DNA methylation and gene expression across blood and brain regions in suicide victims	7
Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review	7
Role of appetite hormone dysregulation in the cognitive function among patients with bipolar disorder and major depressive disorder	7
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis	6
Alexithymia and cortisol awakening response in people with eating disorders	6
Association of treatment facets, severity of manic symptoms, psychomotor disturbances and psychotic features with response to electroconvulsive therapy in bipolar depression	6
Sensorimotor and sensory gating in depression, anxiety, and their comorbidity	6

Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples	6
5-HT_2A receptor-mediated Gα_q/11 activation in psychiatric disorders: A postmortem study	6
Effects of testosterone suppression on desire, hypersexuality, and sexual interest in children in men with pedophilic disorder	6
Associations between depressive symptom profiles and immunometabolic characteristics in individuals with depression and their siblings	6
Altered expression levels of miR-144-3p and ATP1B2 are associated with schizophrenia	6
General cognitive ability assessment in the German National Cohort (NAKO) – The block-adaptive number series task	6
Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder	6
Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia	6
Treatment-resistant depression: Neurobiological correlates and the effect of sleep deprivation with sleep phase advance for the augmentation of pharmacotherapy	6
Metabolic syndrome components and leukocyte telomere length in patients with major depressive disorder	6
Left handedness and response to repetitive transcranial magnetic stimulation in major depressive disorder	5
Mortality and acute somatic events following electroconvulsive therapy in patients with pre-existing somatic comorbidity – A register-based nationwide Danish cohort study	5
Metabolic indices in schizophrenia: Association of negative symptoms with higher HDL cholesterol in female patients	5
Expression of the adult ADHD-associated gene ADGRL3 is dysregulated by risk variants and environmental risk factors	5
Effects of psychoactive drugs on cellular bioenergetic pathways	5
The association between prolactin concentration and aggression in female patients with schizophrenia	5
Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression	5
Handedness as a neurodevelopmental marker in schizophrenia: Results from the FACE-SZ cohort	5
Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder	5
Ventricular volume, white matter alterations and outcome of major depression and their relationship to endocrine parameters – A pilot study	5
Potential bioelectrical impedance analysis (BIA) parameters in prediction muscle strength in women with anorexia nervosa	5
NBQX attenuates relapse of nicotine seeking but not nicotine and methamphetamine self-administration in rats	5
Sex difference in lipid levels in first-diagnosed drug-naïve depression patients: A case-control and 12-weeks follow-up study	4
Polygenic risk for traumatic loss-related PTSD in US military veterans: Protective effect of secure attachment style	4
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia	4
Systematic review of genome-wide association studies of anxiety disorders and neuroticism	4
Depressive symptoms are not associated with long-term integrated testosterone concentrations in hair	4
SMAD4 protein is decreased in the dorsolateral prefrontal and anterior cingulate cortices in schizophrenia	4
A systematic review and meta-analysis of optical coherence tomography studies in schizophrenia, bipolar disorder and major depressive disorder	4
Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia	4
14-3-3 proteins at the crossroads of neurodevelopment and schizophrenia	4
Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials	4
KEOPS complex expression in the frontal cortex in major depression and schizophrenia	4
The pattern of inflammatory markers during electroconvulsive therapy in older depressed patients	4
Genes involved in glucocorticoid receptor signalling affect susceptibility to mood disorders	4
BST-1 as a serum protein biomarker involved in neutrophil infiltration in schizophrenia	3
Investigating pupillometry to detect emotional regulation difficulties in post-traumatic stress disorder	3
Novel anti-cytoplasmic antibodies in cerebrospinal fluid and serum of patients with chronic severe mental disorders	3
Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder	3
Physical activity and childhood trauma experiences in patients with schizophrenia or bipolar disorders	3
DNA methylation in people with anorexia nervosa: Epigenome-wide patterns in actively ill, long-term remitted, and healthy-eater women	3
Inflammatory and oxidative endophenotypes in borderline personality disorder: A biomarker cluster analysis	3
Relationships between global functioning and neuropsychological predictors in subjects at high risk of psychosis or with a recent onset of depression	3
Endocannabinoids and addiction memory: Relevance to methamphetamine/morphine abuse	3
Neurocognitive profile of adolescents with early-onset schizophrenia and their unaffected siblings	3
A novel genetic variant potentially altering the expression of MANBA in the cerebellum associated with attention deficit hyperactivity disorder in Han Chinese children	3
Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients	3
Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder?	3
Volatile organic compounds from exhaled breath in schizophrenia	3
Evidence and expert consensus based German guidelines for the use of repetitive transcranial magnetic stimulation in depression	3